A side door into care cascade for HIV-infected patients?

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue SUPPL. 2, 2013, Pages

  Hallett, Timothy B ^a   Eaton, Jeffrey W ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

ART programs; HIV care cascade; Side door; Surveillance

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; HEALTH STATUS; HELP SEEKING BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; LONG TERM CARE; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME; ZAMBIA;

ANTI-RETROVIRAL AGENTS; HEALTH BEHAVIOR; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; SENTINEL SURVEILLANCE;

EID: 84880239898     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318298721b     Document Type: Article

References (29)

1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
2. Sterne JAC, May M, Costagliola D, et al. Timing of initiation of anti-retroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352-1363.
3. Bor J, Herbst AJ, Newell M-L, et al. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013; 339:961-965.
4. Tanser F, Bärnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966-971.
5. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic 2012. Geneva, Switzerland: UNAIDS; 2012:103.
6. Boily M-C, Mâsse B, Alsallaq R, et al. HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med. 2012;9: e1001250.
7. Wanyenze RK, Kamya MR, Fatch R, et al. Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One. 2011;6:1-11.
8. Drain PK, Losina E, Parker G, et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS One. 2013;8:e55305.
9. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.
10. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010;15(suppl 1):1-15.
11. Menzies NA, Berruti AA, Berzon R, et al. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS. 2011; 25:1753-1760.
12. McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS. 2012;26:1735-1738.
13. Micek MA, Gimbel-Sherr K, Baptista AJ, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;52:397-405.
14. Fox MP, Larson B, Rosen S. Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa. Trop Med Int Health. 2012;17:1235-1244.
15. Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, et al. Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PloS One. 2012;7:e37125.
16. Lahuerta M, Ue F, Hoffman S, et al. The problem of late ART initiation in sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved 2013;24:359-383.
17. Kilmarx PH, Mutasa-Apollo T. Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS. 2013;8:59-64.
18. Bärnighausen T, Chaiyachati K, Chimbindi N, et al. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011;11:942-951.
19. Zambia National AIDS Council. Zambia Country Report: Monitoring the Declaration of Commitment on HIV and AIDS and the Universal Access, Biennial Report. Zambia: Zambia National AIDS Council; 2012: 51.
20. World Health Organization, Joint United Nations Programme on HIV/AIDS (UNAIDS). Guidance on Provider-Initiated HIV Testing and Counselling in Health Facilities. UNAIDS; 2007:60.
21. Geng EH, Glidden DV, Bwana MB, et al. Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One. 2011;6 (7):e21797. doi: 10.1371/journal.pone.0021797.
22. Bor J, Tanser F, Newell M-L, et al. In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff. 2012;31:1459-1469.
23. Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet. 2008;371: 752-759.
24. Central Statistical Office, Ministry of Health, Tropical Diseases Research Centre, University of Zambia, Macro International Inc. Zambia Demographic and Health Survey 2007. Zambia: University of Zambia; 2009; 482.
25. Reniers G, Eaton J. Refusal bias in HIV prevalence estimates from nationally representative seroprevalence surveys. AIDS. 2009;23:621-629.
26. Bärnighausen T, Bor J, Wandira-Kazibwe S, et al. Correcting HIV prevalence estimates for survey nonparticipation using Heckman-type selection models. Epidemiology. 2011;22:27-35.
27. Todd J, Glynn JR, Marston M, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS. 2007; 21(suppl 6):S55-S63.
28. 3: assessment of need following changes in treatment guidelines. Clin Infect Dis. 2011;53:817-825.
29. Pantazis N, Morrison C, Amornkul PN, et al. Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa. PLoS One 2012;7:e32369.